Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Parthasarathy Chandrakesan, Randal May, Dongfeng Qu, Nathaniel Weygant, Vivian E. Taylor, James D. Li, Naushad Ali, Sripathi M. Sureban, Michael Qante, Timothy C. Wang, Michael S. Bronze, Courtney W. Houchen
Published Sep 2, 2015 · Vol. 6, No. 31 · pp. 30876-30886
Adil El Taghdouini, Anita L. Sørensen, Andrew H. Reiner, Mar Coll, Stefaan Verhulst, Inge Mannaerts, Cristina I. Øie, Bård Smedsrød, Mustapha Najimi, Etienne Sokal, Aernout Luttun, Pau Sancho-Bru, Philippe Collas, Leo A. van Grunsven
Published Aug 31, 2015 · Vol. 6, No. 29 · pp. 26729-26745
Michael Timaner, Rotem Bril, Orit Kaidar-Person, Chen Rachman-Tzemah, Dror Alishekevitz, Ruslana Kotsofruk, Valeria Miller, Alexander Nevelsky, Shahar Daniel, Ziv Raviv, Susan A. Rotenberg, Yuval Shaked
Published Aug 6, 2015 · Vol. 6, No. 29 · pp. 27537-27554